Cellular Cancer Markers (inbunden)
Fler böcker inom
Format
Inbunden (Hardback)
Språk
Engelska
Antal sidor
484
Utgivningsdatum
1995-03-01
Upplaga
1995 ed.
Förlag
Humana Press Inc.
Medarbetare
Garrett, Carleton T. (ed.), Sell, Stewart (ed.)
Illustrationer
XII, 484 p.
Dimensioner
234 x 156 x 27 mm
Vikt
872 g
Antal komponenter
1
Komponenter
1 Hardback
ISBN
9780896032101

Cellular Cancer Markers

Contemporary Biomedicine

av Carleton T Garrett, Stewart Sell
Inbunden,  Engelska, 1995-03-01
3086
Köp
Spara som favorit
  • Skickas från oss inom 7-10 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers reviewed have been chosen because they are biologically relevant to the growth of cells and possess an accurate and reproducible assay for detection. They also are predictors of tumor behavior, are useful in making clinical decisions, and are cost effective. Cellular Cancer Markers provides a status report for markers of tumor cell activation, proliferation, and longevity that makes possible an informed judgment regarding the value of many newly proposed tumor markers. It also offers insight into the latest approaches to diagnosing cancer and an appreciation of how these marker-based tests can clarify the prognosis of cancer.
Visa hela texten

Passar bra ihop

  1. Cellular Cancer Markers
  2. +
  3. Foundations for Health Promotion

De som köpt den här boken har ofta också köpt Foundations for Health Promotion av Jane Wills (häftad).

Köp båda 2 för 3477 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Carleton T Garrett, Stewart Sell

Recensioner i media

The editors should be commended for attempting an extensive compilation of information on cancer markers...-New England Journal of Medicine

Innehållsförteckning

Ch. 1. Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer.- Ch. 2. ras Proto-Oncogene Activation in Human Malignancy.- Ch. 3. C-myc as a Tumor Marker for Primary Human Cancers.- Ch. 4. p53 in Human Cancer.- Ch. 5. Oncogenes and Tumor-Suppressor Genes in Gynecological Malignancies.- Ch. 6. Genetic Alterations in Colon Cancer.- Ch. 7. Genetic Changes in Breast Cancer.- Ch. 8. Genetic Alterations in Lung Cancer.- Ch. 9. Wilms Tumor-Susceptibility Loci.- Ch. 10. Non-Hodgkins Lymphomas.- Ch. 11. Phenotypic Expression of Hodgkins Disease: Biologic, Immunologic, and Functional Properties of Reed-Sternberg Cells.- Ch. 12. Melanoma Markers.- Ch. 13. Detection of Minimal Residual Disease (MRD) in Leukemia and Lymphoma.- Ch. 14. P-Glycoproteins in Tumors.- Ch. 15. Genetically Engineered Antitumor Monoclonal Antibodies.- Ch. 16. Targeting Antisense Oligonucleotide Chemotherapy to the Type I Regulatory Subunit of cAMP-Dependent Protein Kinase.- Ch. 17. Summary and Perspective: Assessing Test EffectivenessThe Identification of Good Tumor Markers.

Du kanske gillar